Skip to main content

Orasure Technologies

OraSure Technologies Inc is an American medical diagnostics and sample collection technology company manufacturing rapid diagnostic tests and collection devices. The company manufactures rapid HIV tests (OraQuick), in-home COVID-19 tests, oral fluid collection devices, and biological sample collection kits (DNA Genotek) utilized in molecular diagnostics. Main revenue drivers comprise global commercial sales of rapid diagnostic test kits, molecular sample collection devices, and lab diagnostic reagents to public health bodies and consumer retail markets. OraSure serves public health agencies, hospital networks, clinical research labs, consumer retail buyers, and diagnostic partners across North America, Europe, and Asia. The company holds a market-leading position in rapid point-of-care oral fluid HIV testing and biological sample collection tools. Headquartered in Bethlehem, Pennsylvania, OraSure Technologies Inc is listed on the Nasdaq Stock Market.

2 of the funds FundTelligence covers report a position in Orasure Technologies.

Legal name
ORASURE TECHNOLOGIES INC
Sector
Health Care
Country
United States
Funds holding it
2

Funds holding Orasure Technologies

Loading...